Orange Book product · Generic (ANDA)
RIFAXIMIN
RIFAXIMIN
Generic (ANDA)ANDA 208959TE ABRX ACTAVIS LABS FL INC
At a glance
Mar 19, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 19, 2026
3 mo ago
Today
Pharmaceutical detail
Active ingredient
RIFAXIMIN
Strength
550MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 208959
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of RIFAXIMIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
